These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 19640218)
41. The pros and cons of multiplexing: a guest-editor's introduction. Lewczuk P Methods; 2012 Apr; 56(4):461-3. PubMed ID: 22691822 [No Abstract] [Full Text] [Related]
43. Value of new biomarkers for safety testing in drug development. Hewitt P; Herget T Expert Rev Mol Diagn; 2009 Sep; 9(6):531-6. PubMed ID: 19731999 [No Abstract] [Full Text] [Related]
44. Drug discovery. Repurposing with a difference. Boguski MS; Mandl KD; Sukhatme VP Science; 2009 Jun; 324(5933):1394-5. PubMed ID: 19520944 [No Abstract] [Full Text] [Related]
45. Let's get some structure into neuroscience drug discovery. England S Curr Opin Investig Drugs; 2009 Jul; 10(7):622-3. PubMed ID: 19579167 [No Abstract] [Full Text] [Related]
46. This issue introduces a set of ideas called "Distributed Drug Discovery (D(3))". Czarnik AW J Comb Chem; 2009; 11(1):1-2. PubMed ID: 19133837 [No Abstract] [Full Text] [Related]
47. In vivo model of pseudomyxoma peritonei for novel candidate drug discovery. Chua TC; Akther J; Yao P; Morris DL Anticancer Res; 2009 Oct; 29(10):4051-5. PubMed ID: 19846950 [TBL] [Abstract][Full Text] [Related]
48. Selective attachment of antibodies to the edges of gold nanostructures for enhanced localized surface plasmon resonance biosensing. Beeram SR; Zamborini FP J Am Chem Soc; 2009 Aug; 131(33):11689-91. PubMed ID: 19650650 [TBL] [Abstract][Full Text] [Related]
50. Purposeful learning with drug repurposing. Toney JH; Fasick JI; Singh S; Beyrer C; Sullivan DJ Science; 2009 Sep; 325(5946):1339-40. PubMed ID: 19745134 [No Abstract] [Full Text] [Related]
51. Guest editor's introduction: Special section on the IEEE Pacific Visualization Symposium. North S; Shen HW; van Wijk JJ IEEE Trans Vis Comput Graph; 2011 Nov; 17(11):1545-6. PubMed ID: 21885894 [No Abstract] [Full Text] [Related]
52. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Braam SR; Passier R; Mummery CL Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090 [TBL] [Abstract][Full Text] [Related]
53. A rebinding-assay for measuring extreme kinetics using label-free biosensors. Quinn JG Sci Rep; 2021 Apr; 11(1):8301. PubMed ID: 33859320 [TBL] [Abstract][Full Text] [Related]
54. Chutes and ladders on the critical path:comparative effectiveness, product value, and the use of biomarkers in drug development. Woodcock J Clin Pharmacol Ther; 2009 Jul; 86(1):12-4. PubMed ID: 19536116 [No Abstract] [Full Text] [Related]
55. New screens and targets in antibacterial drug discovery. Falconer SB; Brown ED Curr Opin Microbiol; 2009 Oct; 12(5):497-504. PubMed ID: 19651534 [TBL] [Abstract][Full Text] [Related]
56. Christian K. Schneider. Interview by Bethan Hughes. Schneider CK Nat Rev Drug Discov; 2009 Apr; 8(4):270. PubMed ID: 19337268 [No Abstract] [Full Text] [Related]
57. No let up in the search for novel antibiotics. Payne DJ; Portnoy A; Pottage J; Hong Z Expert Rev Anti Infect Ther; 2009 May; 7(4):397. PubMed ID: 19400756 [No Abstract] [Full Text] [Related]
58. The road ahead for large pharma: long-term science and innovation. Lundberg JM; Reilly C Drug Discov Today; 2009 May; 14(9-10):439-41. PubMed ID: 19429501 [No Abstract] [Full Text] [Related]
59. Enhanced surface plasmon resonance by Au nanoparticles immobilized on a dielectric SiO2 layer on a gold surface. Jung J; Na K; Lee J; Kim KW; Hyun J Anal Chim Acta; 2009 Sep; 651(1):91-7. PubMed ID: 19733741 [TBL] [Abstract][Full Text] [Related]